| The contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies C Zhu, JM Kros, C Cheng, D Mustafa Neuro-oncology 19 (11), 1435-1446, 2017 | 153 | 2017 |
| Activation of CECR1 in M2-like TAMs promotes paracrine stimulation-mediated glial tumor progression C Zhu, D Mustafa, P Zheng, M van der Weiden, A Sacchetti, M Brandt, ... Neuro-oncology 19 (5), 648-659, 2017 | 73 | 2017 |
| Expression site of P2RY12 in residential microglial cells in astrocytomas correlates with M1 and M2 marker expression and tumor grade C Zhu, JM Kros, M van der Weiden, PP Zheng, C Cheng, DAM Mustafa Acta Neuropathologica Communications 5, 1-12, 2017 | 71 | 2017 |
| CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma C Zhu, I Chrifi, D Mustafa, M van der Weiden, PJM Leenen, DJ Duncker, ... Oncogene 36 (38), 5356-5368, 2017 | 71 | 2017 |
| CMTM4 regulates angiogenesis by promoting cell surface recycling of VE-cadherin to endothelial adherens junctions I Chrifi, L Louzao-Martinez, MM Brandt, CGM Van Dijk, PE Bürgisser, ... Angiogenesis 22, 75-93, 2019 | 61 | 2019 |
| Deciphering the epitranscriptome in cancer H Lian, QH Wang, CB Zhu, J Ma, WL Jin Trends in cancer 4 (3), 207-221, 2018 | 45 | 2018 |
| Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high‐risk Chinese individuals D Shao, S Cheng, F Guo, C Zhu, Y Yuan, K Hu, Z Wang, X Meng, X Jin, ... Cancer science 111 (2), 647-657, 2020 | 34 | 2020 |
| Periostin is expressed by pericytes and is crucial for angiogenesis in glioma K Huizer, C Zhu, I Chirifi, B Krist, D Zorgman, M van der Weiden, ... Journal of Neuropathology & Experimental Neurology 79 (8), 863-872, 2020 | 33 | 2020 |
| CMTM3 (CKLF-like marvel transmembrane domain 3) mediates angiogenesis by regulating cell surface availability of VE-cadherin in endothelial adherens junctions I Chrifi, L Louzao-Martinez, M Brandt, CGM Van Dijk, P Burgisser, C Zhu, ... Arteriosclerosis, thrombosis, and vascular biology 37 (6), 1098-1114, 2017 | 33 | 2017 |
| Cgnl1, an endothelial junction complex protein, regulates GTPase mediated angiogenesis I Chrifi, D Hermkens, MM Brandt, CGM Van Dijk, PE Bürgisser, R Haasdijk, ... Cardiovascular Research 113 (14), 1776-1788, 2017 | 28 | 2017 |
| Risk factors stratifying malignancy of nodules in contralateral thyroid lobe in patients with pre‐operative ultrasound indicated unilateral papillary thyroid carcinoma: a … T Lv, C Zhu, Z Di Clinical endocrinology 88 (2), 279-284, 2018 | 26 | 2018 |
| Concomitant mutations in EGFR 19Del/L858R mutation and their association with response to EGFR-TKIs in NSCLC patients H Liang, C Li, Y Zhao, S Zhao, J Huang, X Cai, B Cheng, S Xiong, J Li, ... Cancer Management and Research, 8653-8662, 2020 | 17 | 2020 |
| Incidence of metastatic disease and survival among patients with newly diagnosed primary CNS tumors in the United States from 2004-2013 H Lian, C Daniels, YP Han, QF Li, Y Zhao, BC Wang, CB Zhu, WW Mao, ... Journal of Cancer 10 (13), 3037, 2019 | 14 | 2019 |
| Reliability and validity of the Chinese version appropriateness evaluation protocol W Liu, S Yuan, F Wei, J Yang, Z Zhang, C Zhu, J Ma PloS one 10 (8), e0136498, 2015 | 14 | 2015 |
| Integrating histologic and genomic characteristics to predict tumor mutation burden of early-stage non-small-cell lung cancer Y Qiu, L Liu, H Yang, H Chen, Q Deng, D Xiao, Y Lin, C Zhu, W Li, D Shao, ... Frontiers in Oncology 10, 608989, 2021 | 13 | 2021 |
| Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm … X Han, X Tang, H Zhu, D Zhu, X Zhang, X Meng, Y Hua, Z Wang, Y Zhang, ... Journal for Immunotherapy of Cancer 10 (12), 2022 | 11 | 2022 |
| Detecting ALK Rearrangement with RT-PCR: A Reliable Approach Compared with Next-Generation Sequencing in Patients with NSCLC Y Kuang, P Xu, J Wang, Y Zheng, X Sun, Z Li, RJ Gan, H Li, Y Guo, F Yao, ... Molecular Diagnosis & Therapy 25 (4), 487-494, 2021 | 11 | 2021 |
| Unique profile of driver gene mutations in patients with non-Small-Cell lung cancer in qujing city, yunnan province, southwest China Y Zhou, F Ge, Y Du, Q Li, J Cai, X Liu, Y Guo, Z Shen, L Duan, Z Huang, ... Frontiers in Oncology 11, 644895, 2021 | 11 | 2021 |
| Inappropriate hospital days of a tertiary hospital in Shanghai, China W Liu, S Yuan, F Wei, J Yang, C Zhu, Y Yu, J Ma International Journal for Quality in Health Care 29 (5), 699-704, 2017 | 11 | 2017 |
| PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma J Liu, H Chen, G Qiao, JT Zhang, S Zhang, C Zhu, Y Chen, J Tang, W Li, ... Cancer Immunology, Immunotherapy 72 (4), 881-893, 2023 | 9 | 2023 |
